Correlation Between Syndax Pharmaceuticals and MEI Pharma

Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and MEI Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and MEI Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Syndax Pharmaceuticals and MEI Pharma, you can compare the effects of market volatilities on Syndax Pharmaceuticals and MEI Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of MEI Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and MEI Pharma.

Diversification Opportunities for Syndax Pharmaceuticals and MEI Pharma

0.31

Correlation Coefficient

Syndax Pharmaceuticals  MEI Pharma

Weak diversification

The 3 months correlation between Syndax and MEI is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and MEI Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MEI Pharma and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with MEI Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MEI Pharma has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and MEI Pharma go up and down completely randomly.

Pair Corralation between Syndax Pharmaceuticals and MEI Pharma

Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to under-perform the MEI Pharma. In addition to that, Syndax Pharmaceuticals is 1.78 times more volatile than MEI Pharma. It trades about -0.07 of its total potential returns per unit of risk. MEI Pharma is currently generating about -0.07 per unit of volatility. If you would invest  305.00  in MEI Pharma on September 16, 2024 and sell it today you would lose (35.00) from holding MEI Pharma or give up 11.48% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Syndax Pharmaceuticals  vs.  MEI Pharma

Syndax Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Syndax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

MEI Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MEI Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with Syndax Pharmaceuticals and MEI Pharma

The main advantage of trading using opposite Syndax Pharmaceuticals and MEI Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, MEI Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will offset losses from the drop in MEI Pharma's long position.

The idea behind Syndax Pharmaceuticals and MEI Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.